13748-10-9 Purity
99%
If you have any other questions or need other size, please get a quote.
Specification
Gentamicin is the most kidney damaging aminoglycoside. In this experiment, researchers tried to compare the renal efficacy of gentamicin and a new nanoformulation of the drug in a mouse model. This article demonstrated that gentamicin degenerated the renal proximal tubular cells severely, and induced increases in serum creatinine and BUN. But they did not experience major injury after nano-gentamicin treatment, which suggests that nano-gentamicin is less nephrotoxic.
Nanoparticle Preparation and Loading
· The ionic gelation method involving gentamicin sulfate and sodium alginate was employed to create nanoparticles of a suitable size. An aqueous solution of alginate was prepared, and gentamicin sulfate solution was gradually added while mixing, resulting in nanoparticles of the desired size depending on the proportions used. The preparation process was optimized by adjusting the volume of the drug and maintaining a constant polymer volume at various mixing rates.
· The influence of these different variables on particle size distribution and release profiles was then analyzed. To achieve optimal particle size distribution, an orthogonal factorial design was implemented using Minitab 16 software, resulting in an average nanoparticle size of 80 nm in the optimized formulation. The loading efficiency of the optimized nanoparticles was found to be 85%. Additionally, the physical stability of the particles was deemed acceptable at room temperature and in refrigerated conditions throughout a 3-month study period.
Gentamicin-loaded poly(lactide-co-glycolide) (PLGA) nanoparticles were developed to achieve controlled release of the antibiotic. Experimental results demonstrated that the antimicrobial efficacy of gentamicin against both planktonic and biofilm infections, both in vitro and in vivo, could be enhanced through optimized encapsulation and release from PLGA nanoparticles.
Preparation of Gentamicin-Loaded PLGA Nanoparticles
A water-in-oil-in-water (w/o/w) emulsion technique was employed for nanoparticle formulation. Gentamicin (3.5 mg) was dissolved in 0.5 mL of water and emulsified with 100 mg of PLGA dissolved in 2 mL of dichloromethane using 20 mV sonication. The primary water-in-oil (w/o) emulsion was then dispersed in 10 mL of aqueous polyvinyl alcohol (PVA) solution (2.5% in 25 mM MES buffer) at varying pH values (5 to 7.4) to form the final w/o/w emulsion.
For solid-in-oil-in-water (s/o/w) formulations, 3.5 mg of gentamicin was dissolved in 0.1 mL of water and added to 2 mL of acetone containing 100 mg of PLGA. As water diffuses into the acetone, solid gentamicin nanoparticles form. This solid phase was added to 10 mL of PVA (2.5% in 25 mM MES buffer) at two pH values (pH 5 and 7.4). The acetone and the aqueous PVA phase combined to coat the gentamicin with PLGA, creating gentamicin-encrusted PLGA nanoparticles.
High purity material
The gentamicinsulfate salt purchased on this platform has various specifications, and it has the purity selection that meets its own expectations.
The molecular formula of Gentamicinsulfate salt is C60H123N15O21.
Some synonyms for Gentamicinsulfate salt are Gentamicin sulfate, CHEMBL3039597, BDBM50476074, and G-2419.
Gentamicinsulfate salt was created on October 25, 2006, and modified on August 26, 2023.
The IUPAC name of Gentamicinsulfate salt is (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol.
The InChI of Gentamicinsulfate salt is InChI=1S/C21H43N5O7.C20H41N5O7.C19H39N5O7/c1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20;1-8(21)12-5-4-9(22)18(30-12)31-15-10(23)6-11(24)16(13(15)26)32-19-14(27)17(25-3)20(2,28)7-29-19;1-19(27)7-28-18(13(26)16(19)24-2)31-15-11(23)5-10(22)14(12(15)25)30-17-9(21)4-3-8(6-20)29-17/h9-20,25-29H,5-8,22-24H2,1-4H3;8-19,25-28H,4-7,21-24H2,1-3H3;8-18,24-27H,3-7,20-23H2,1-2H3/t9?,10-,11+,12-,13+,14+,15-,16-,17+,18-,19-,20-,21+;8?,9-,10+,11-,12+,13+,14-,15-,16+,17-,18-,19-,20+;8-,9+,10-,11+,12-,13+,14+,15-,16+,17+,18+,19-/m110/s1.
The InChIKey of Gentamicinsulfate salt is NPEFREDMMVQEPL-RWPARATISA-N.
The molecular weight of Gentamicinsulfate salt is 1390.7g/mol.
Gentamicinsulfate salt has 24 hydrogen bond donor counts.
Gentamicinsulfate salt has 36 hydrogen bond acceptor counts.
Gentamicinsulfate salt has 19 rotatable bond counts.